Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-267,500
Closed -$26.4M 132
2014
Q3
$26.4M Buy
267,500
+217,500
+435% +$20.5M 0.96% 26
2014
Q2
$4.66M Buy
+50,000
New +$4.31M 0.3% 71

Other funds holding ASML

Maplelane Capital's ASML Position: Q1 2026 in Review

Maplelane Capital reduced its ASML (ASML) stake by 45% in Q1 2026, selling an estimated $17.1M and leaving 15,000 shares worth $19.8M. The position accounts for 0.71% of the portfolio, ranked #41.

Maplelane Capital first reported a position in ASML in Q2 2014 and has held it in 11 quarters since. The position peaked at $95.5M in Q2 2024. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • Maplelane Capital held 15,000 shares of ASML worth $19.8M as of Q1 2026.
  • Maplelane Capital sold 12,500 ASML shares in Q1 2026, an estimated $17.1M.
  • ASML made up 0.71% of Maplelane Capital's portfolio in Q1 2026, its #41 holding.
  • Maplelane Capital first reported a position in ASML in Q2 2014 and has held it in 11 quarters since.
  • Maplelane Capital's ASML position peaked at $95.5M in Q2 2024.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Maplelane Capital's 13F filing for Q1 2026, filed 14 May 2026.